Literature DB >> 21606569

Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.

Panagiotis Alexopoulos1, Tanja Richter-Schmidinger, Marco Horn, Sebastian Maus, Martin Reichel, Christos Sidiropoulos, Cosima Rhein, Piotr Lewczuk, Arnd Doerfler, Johannes Kornhuber.   

Abstract

The apolipoprotein E (APOE) ε4 allele is the major genetic risk factor for the development of late-onset Alzheimer's disease (AD), whereas the presence of the APOE ε2 allele seems to confer protection. Here, we report that healthy young APOE ε4 carriers have statistically significantly smaller hippocampal volumes than APOE ε2 carriers, while no differences were detected between the two groups in memory performance. The difference in hippocampal morphology is cognitively/clinically silent in young adulthood, but could render APOE ε4 carriers more prone to the later development of AD possibly due to lower reserve cognitive capacity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606569     DOI: 10.3233/JAD-2011-110356

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  32 in total

1.  Lifespan brain activity, β-amyloid, and Alzheimer's disease.

Authors:  William J Jagust; Elizabeth C Mormino
Journal:  Trends Cogn Sci       Date:  2011-10-07       Impact factor: 20.229

Review 2.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

3.  Sex, but not Apolipoprotein E Polymorphism, Differences in Spatial Performance in Young Adults.

Authors:  Alia L Yasen; Jacob Raber; Jeremy K Miller; Brian J Piper
Journal:  Arch Sex Behav       Date:  2015-03-07

Review 4.  APOE in the normal brain.

Authors:  Sarah A Flowers; G William Rebeck
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

5.  Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans.

Authors:  Gali H Weissberger; Daniel A Nation; Caroline P Nguyen; Mark W Bondi; S Duke Han
Journal:  Neurosci Biobehav Rev       Date:  2018-08-17       Impact factor: 8.989

Review 6.  Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.

Authors:  Niyatee Samudra; Neepa Patel; Kyle B Womack; Pravin Khemani; Shilpa Chitnis
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

Review 7.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

Review 8.  The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations.

Authors:  Elizabeth C Mormino
Journal:  Neuropsychol Rev       Date:  2014-08-10       Impact factor: 7.444

Review 9.  Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function.

Authors:  Amanda M Di Battista; Nicolette M Heinsinger; G William Rebeck
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

10.  APOE polymorphisms and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Raymond E Baser; Kenneth Cheung; Elizabeth Richards; Michael Lin; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neurology       Date:  2014-06-18       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.